S19-060 Genetically corrected, iPSC-derived epithelial sheets to treat RDEB Researchers at Stanford have developed a targeted gene therapy approach to treat patients with recessive dystrophic epidermolysis bullosa (RDEB). Anthony Oro Marius Wernig
S20-212 A new method for prioritizing non-coding genetic variants associated with complex diseases Because 98% of the genome does not code for a protein, unraveling how non-coding genetic variants contribute to complex diseases remains a great challenge. Anthony Oro Sam Piekos